nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—cardiac ventricle—dilated cardiomyopathy	0.0366	0.183	CbGeAlD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—ZBTB17—dilated cardiomyopathy	0.0351	0.0652	CbGpPWpGaD
Rifabutin—HSP90B1—myocardium—dilated cardiomyopathy	0.0344	0.172	CbGeAlD
Rifabutin—HSP90AA1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.031	0.0576	CbGpPWpGaD
Rifabutin—HSP90AA1—cardiac ventricle—dilated cardiomyopathy	0.0267	0.134	CbGeAlD
Rifabutin—HSP90AA1—myocardium—dilated cardiomyopathy	0.0251	0.126	CbGeAlD
Rifabutin—HSP90B1—heart—dilated cardiomyopathy	0.024	0.12	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.023	0.0882	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0215	0.0399	CbGpPWpGaD
Rifabutin—HSP90B1—cardiac atrium—dilated cardiomyopathy	0.0205	0.103	CbGeAlD
Rifabutin—HSP90AA1—heart—dilated cardiomyopathy	0.0176	0.0878	CbGeAlD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0153	0.0284	CbGpPWpGaD
Rifabutin—HSP90AA1—Loss of Nlp from mitotic centrosomes—TUBB—dilated cardiomyopathy	0.0151	0.028	CbGpPWpGaD
Rifabutin—HSP90AA1—cardiac atrium—dilated cardiomyopathy	0.015	0.0751	CbGeAlD
Rifabutin—HSP90B1—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.0141	0.0261	CbGpPWpGaD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—LMNA—dilated cardiomyopathy	0.0138	0.0257	CbGpPWpGaD
Rifabutin—HSP90AA1—Centrosome maturation—TUBB—dilated cardiomyopathy	0.0134	0.0248	CbGpPWpGaD
Rifabutin—HSP90AA1—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.0127	0.0235	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—TUBB—dilated cardiomyopathy	0.0123	0.0228	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—RAC1—dilated cardiomyopathy	0.0119	0.0221	CbGpPWpGaD
Rifabutin—HSP90AA1—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.0112	0.0208	CbGpPWpGaD
Rifabutin—HSP90AA1—Sema3A PAK dependent Axon repulsion—RAC1—dilated cardiomyopathy	0.011	0.0204	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.0103	0.0191	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.00991	0.0184	CbGpPWpGaD
Rifabutin—HSP90AA1—G2/M Transition—TUBB—dilated cardiomyopathy	0.00922	0.0171	CbGpPWpGaD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—TUBB—dilated cardiomyopathy	0.0091	0.0169	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VCL—dilated cardiomyopathy	0.00909	0.0169	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VCL—dilated cardiomyopathy	0.00856	0.0159	CbGpPWpGaD
Rifabutin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00842	0.0322	CcSEcCtD
Rifabutin—HSP90AA1—G2/M Transition—ALMS1—dilated cardiomyopathy	0.00773	0.0143	CbGpPWpGaD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.00762	0.0141	CbGpPWpGaD
Rifabutin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00707	0.0271	CcSEcCtD
Rifabutin—HSP90AA1—VEGFR2 mediated vascular permeability—RAC1—dilated cardiomyopathy	0.00702	0.013	CbGpPWpGaD
Rifabutin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00625	0.0239	CcSEcCtD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—RPS6KB1—dilated cardiomyopathy	0.00622	0.0115	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00619	0.0115	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00619	0.0115	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00597	0.0111	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—RAC1—dilated cardiomyopathy	0.00562	0.0104	CbGpPWpGaD
Rifabutin—HSP90AA1—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00549	0.0102	CbGpPWpGaD
Rifabutin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0053	0.0203	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—PSEN2—dilated cardiomyopathy	0.0053	0.00984	CbGpPWpGaD
Rifabutin—HSP90AA1—ErbB receptor signaling network—EGFR—dilated cardiomyopathy	0.00526	0.00976	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00524	0.00972	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00518	0.00961	CbGpPWpGaD
Rifabutin—HSP90AA1—NOD pathway—RAC1—dilated cardiomyopathy	0.00518	0.00961	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00501	0.0093	CbGpPWpGaD
Rifabutin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00487	0.0186	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events—RAC1—dilated cardiomyopathy	0.0048	0.00892	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—RAC1—dilated cardiomyopathy	0.0048	0.00892	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00473	0.0181	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—SCN5A—dilated cardiomyopathy	0.00467	0.00867	CbGpPWpGaD
Rifabutin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00458	0.0175	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—ZIC3—dilated cardiomyopathy	0.0044	0.00816	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—EGFR—dilated cardiomyopathy	0.00435	0.00808	CbGpPWpGaD
Rifabutin—HSP90AA1—Semaphorin interactions—ITGB1—dilated cardiomyopathy	0.00435	0.00807	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00417	0.016	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—RPS6KB1—dilated cardiomyopathy	0.00406	0.00754	CbGpPWpGaD
Rifabutin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00398	0.0152	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of actin dynamics for phagocytic cup formation—RAC1—dilated cardiomyopathy	0.00398	0.00738	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0039	0.0149	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events mediated by Akt—RAF1—dilated cardiomyopathy	0.00389	0.00723	CbGpPWpGaD
Rifabutin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00385	0.0147	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.00382	0.00709	CbGpPWpGaD
Rifabutin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00382	0.0146	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—RAC1—dilated cardiomyopathy	0.00367	0.00681	CbGpPWpGaD
Rifabutin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00356	0.0136	CcSEcCtD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—dilated cardiomyopathy	0.00356	0.00661	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00356	0.0066	CbGpPWpGaD
Rifabutin—HSP90AA1—Semaphorin interactions—RAC1—dilated cardiomyopathy	0.00349	0.00649	CbGpPWpGaD
Rifabutin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00346	0.0132	CcSEcCtD
Rifabutin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00344	0.0131	CcSEcCtD
Rifabutin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00342	0.0131	CcSEcCtD
Rifabutin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00341	0.0131	CcSEcCtD
Rifabutin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00334	0.0128	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00333	0.00619	CbGpPWpGaD
Rifabutin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00331	0.0127	CcSEcCtD
Rifabutin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0033	0.0126	CcSEcCtD
Rifabutin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00324	0.0124	CcSEcCtD
Rifabutin—Flatulence—Furosemide—dilated cardiomyopathy	0.00318	0.0121	CcSEcCtD
Rifabutin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00316	0.0121	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00313	0.00581	CbGpPWpGaD
Rifabutin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00307	0.0118	CcSEcCtD
Rifabutin—Rash—Spironolactone—dilated cardiomyopathy	0.00305	0.0117	CcSEcCtD
Rifabutin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00305	0.0116	CcSEcCtD
Rifabutin—Headache—Spironolactone—dilated cardiomyopathy	0.00303	0.0116	CcSEcCtD
Rifabutin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00302	0.0115	CcSEcCtD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—RAC1—dilated cardiomyopathy	0.003	0.00557	CbGpPWpGaD
Rifabutin—Anaemia—Furosemide—dilated cardiomyopathy	0.00298	0.0114	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00293	0.00545	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00293	0.0112	CcSEcCtD
Rifabutin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00289	0.011	CcSEcCtD
Rifabutin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00288	0.011	CcSEcCtD
Rifabutin—Nausea—Spironolactone—dilated cardiomyopathy	0.00287	0.011	CcSEcCtD
Rifabutin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00278	0.0106	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00272	0.0104	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.00271	0.00503	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.00266	0.00495	CbGpPWpGaD
Rifabutin—Confusional state—Furosemide—dilated cardiomyopathy	0.00265	0.0101	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—TUBB—dilated cardiomyopathy	0.00262	0.00487	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.00262	0.00485	CbGpPWpGaD
Rifabutin—Shock—Furosemide—dilated cardiomyopathy	0.00259	0.0099	CcSEcCtD
Rifabutin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00257	0.00985	CcSEcCtD
Rifabutin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00255	0.00977	CcSEcCtD
Rifabutin—Anorexia—Furosemide—dilated cardiomyopathy	0.00251	0.00959	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00246	0.00456	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.00244	0.00453	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.0024	0.00446	CbGpPWpGaD
Rifabutin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00238	0.00911	CcSEcCtD
Rifabutin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00237	0.00906	CcSEcCtD
Rifabutin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00236	0.00903	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—EMD—dilated cardiomyopathy	0.00234	0.00434	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.00229	0.00425	CbGpPWpGaD
Rifabutin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00229	0.00875	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00228	0.00424	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00227	0.00869	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.00227	0.00421	CbGpPWpGaD
Rifabutin—Pain—Furosemide—dilated cardiomyopathy	0.00225	0.0086	CcSEcCtD
Rifabutin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00223	0.00855	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—ALMS1—dilated cardiomyopathy	0.0022	0.00408	CbGpPWpGaD
Rifabutin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00217	0.00829	CcSEcCtD
Rifabutin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00216	0.00828	CcSEcCtD
Rifabutin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00215	0.00823	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00215	0.00398	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.00215	0.00398	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—ACE—dilated cardiomyopathy	0.0021	0.00391	CbGpPWpGaD
Rifabutin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00208	0.00795	CcSEcCtD
Rifabutin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00208	0.00795	CcSEcCtD
Rifabutin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00206	0.00787	CcSEcCtD
Rifabutin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00206	0.00787	CcSEcCtD
Rifabutin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00206	0.00787	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00204	0.00782	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00204	0.00379	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00204	0.00379	CbGpPWpGaD
Rifabutin—Confusional state—Lisinopril—dilated cardiomyopathy	0.00199	0.00761	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00197	0.00366	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—PSEN2—dilated cardiomyopathy	0.00197	0.00366	CbGpPWpGaD
Rifabutin—Shock—Lisinopril—dilated cardiomyopathy	0.00194	0.00743	CcSEcCtD
Rifabutin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00194	0.00741	CcSEcCtD
Rifabutin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00193	0.00739	CcSEcCtD
Rifabutin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00192	0.00733	CcSEcCtD
Rifabutin—Asthenia—Furosemide—dilated cardiomyopathy	0.00189	0.00722	CcSEcCtD
Rifabutin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00188	0.0072	CcSEcCtD
Rifabutin—Pruritus—Furosemide—dilated cardiomyopathy	0.00186	0.00712	CcSEcCtD
Rifabutin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0018	0.00688	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.0018	0.00688	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.0018	0.00334	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.0018	0.00334	CbGpPWpGaD
Rifabutin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00178	0.00683	CcSEcCtD
Rifabutin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00177	0.00678	CcSEcCtD
Rifabutin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00176	0.00673	CcSEcCtD
Rifabutin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00174	0.00664	CcSEcCtD
Rifabutin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00172	0.00656	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00652	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CD36—dilated cardiomyopathy	0.0017	0.00315	CbGpPWpGaD
Rifabutin—Pain—Lisinopril—dilated cardiomyopathy	0.00169	0.00646	CcSEcCtD
Rifabutin—Vomiting—Furosemide—dilated cardiomyopathy	0.00167	0.0064	CcSEcCtD
Rifabutin—Rash—Furosemide—dilated cardiomyopathy	0.00166	0.00634	CcSEcCtD
Rifabutin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00166	0.00634	CcSEcCtD
Rifabutin—Headache—Furosemide—dilated cardiomyopathy	0.00165	0.0063	CcSEcCtD
Rifabutin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00163	0.00622	CcSEcCtD
Rifabutin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00161	0.00617	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—RAC1—dilated cardiomyopathy	0.0016	0.00297	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.00159	0.00296	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.00157	0.00291	CbGpPWpGaD
Rifabutin—Nausea—Furosemide—dilated cardiomyopathy	0.00156	0.00598	CcSEcCtD
Rifabutin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00156	0.00597	CcSEcCtD
Rifabutin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00156	0.00597	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.00156	0.00289	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.0015	0.00279	CbGpPWpGaD
Rifabutin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00145	0.00556	CcSEcCtD
Rifabutin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00142	0.00542	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00141	0.00261	CbGpPWpGaD
Rifabutin—Pruritus—Lisinopril—dilated cardiomyopathy	0.0014	0.00534	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—TMPO—dilated cardiomyopathy	0.00139	0.00258	CbGpPWpGaD
Rifabutin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00135	0.00516	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—AGT—dilated cardiomyopathy	0.00133	0.00248	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.00133	0.00247	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00133	0.00246	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.00128	0.00237	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.00127	0.00236	CbGpPWpGaD
Rifabutin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00125	0.0048	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—TAZ—dilated cardiomyopathy	0.00125	0.00231	CbGpPWpGaD
Rifabutin—Rash—Lisinopril—dilated cardiomyopathy	0.00124	0.00476	CcSEcCtD
Rifabutin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00124	0.00476	CcSEcCtD
Rifabutin—Headache—Lisinopril—dilated cardiomyopathy	0.00124	0.00473	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—ITGB1—dilated cardiomyopathy	0.00123	0.00229	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.00117	0.00218	CbGpPWpGaD
Rifabutin—Nausea—Lisinopril—dilated cardiomyopathy	0.00117	0.00448	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ITGB1—dilated cardiomyopathy	0.00116	0.00215	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—LMNA—dilated cardiomyopathy	0.00114	0.00212	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.00114	0.00211	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SDHA—dilated cardiomyopathy	0.00113	0.00209	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—RAF1—dilated cardiomyopathy	0.00106	0.00197	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00105	0.00196	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00105	0.00194	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00101	0.00188	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—RAC1—dilated cardiomyopathy	0.00099	0.00184	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD36—dilated cardiomyopathy	0.000988	0.00183	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—RAC1—dilated cardiomyopathy	0.000931	0.00173	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000879	0.00163	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.00078	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CD36—dilated cardiomyopathy	0.00075	0.00139	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—dilated cardiomyopathy	0.000727	0.00135	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000717	0.00133	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RAC1—dilated cardiomyopathy	0.000707	0.00131	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NPPA—dilated cardiomyopathy	0.000689	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PSEN2—dilated cardiomyopathy	0.000667	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD36—dilated cardiomyopathy	0.000662	0.00123	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000658	0.00122	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—RAF1—dilated cardiomyopathy	0.000657	0.00122	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000626	0.00116	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RAC1—dilated cardiomyopathy	0.000624	0.00116	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—RAF1—dilated cardiomyopathy	0.000617	0.00115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000589	0.00109	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RAF1—dilated cardiomyopathy	0.000469	0.00087	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000467	0.000867	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ITGB1—dilated cardiomyopathy	0.000452	0.000839	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000451	0.000838	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000451	0.000838	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—dilated cardiomyopathy	0.00045	0.000836	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00043	0.000798	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00043	0.000798	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—dilated cardiomyopathy	0.000423	0.000786	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000415	0.00077	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000415	0.00077	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RAF1—dilated cardiomyopathy	0.000414	0.000768	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000386	0.000716	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD36—dilated cardiomyopathy	0.000386	0.000716	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000374	0.000693	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RAC1—dilated cardiomyopathy	0.000363	0.000675	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RAC1—dilated cardiomyopathy	0.000336	0.000623	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—dilated cardiomyopathy	0.000321	0.000596	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000319	0.000592	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPX1—dilated cardiomyopathy	0.000306	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—dilated cardiomyopathy	0.000306	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000303	0.000562	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CD36—dilated cardiomyopathy	0.000298	0.000554	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—dilated cardiomyopathy	0.000284	0.000527	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000279	0.000518	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AGT—dilated cardiomyopathy	0.000269	0.000498	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000262	0.000487	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00026	0.000483	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RAF1—dilated cardiomyopathy	0.000241	0.000447	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000237	0.00044	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000235	0.000436	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000225	0.000417	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RAF1—dilated cardiomyopathy	0.000223	0.000413	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000215	0.000399	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000202	0.000376	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000183	0.00034	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—dilated cardiomyopathy	0.000165	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000156	0.000289	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—dilated cardiomyopathy	0.000153	0.000283	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000145	0.000268	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000141	0.000261	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000127	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000107	0.000198	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.44e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.27e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.65e-05	0.000105	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.97e-05	9.23e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.84e-05	8.99e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.36e-05	8.09e-05	CbGpPWpGaD
